Congratulations to the corporations and underwriters that worked with our transaction services team. Whether in-house, your-house or 100% virtual… click here to discover why we are the intelligent value for both traditional and confidential IPOs.
|Registrant||Form||Underwriter 1||Underwriter 2||Underwriter 3 +|
|NANOFLEX POWER CORP||S-1||Aegis Capital Corp.||~||~|
|XG TECHNOLOGY INC||S-1||Aegis Capital Corp.||~||~|
|CELLDEX THERAPEUTICS INC||S-3||Cantor Fitzgerald & Co.||~||~|
|VOYAGER THERAPEUTICS INC||S-3||Cowen and Company, LLC||~||~|
|ATKORE INTERNATIONAL GROUP INC||S-1||Credit Suisse Securities LLC||Deutsche Bank Securities Inc.||J.P. Morgan Securities LLC. / UBS Securities LLC|
|LIMBACH HOLDINGS INC||S-1||D.A. Davidson & Co.||Craig-Hallum Capital Group LLC||~|
|HI-CRUSH PARTNERS LP||S-3||Hi-Crush Proppants LLC||~|
|IMMUNE PHARMACEUTICALS INC||S-3||HLHW IV, LLC||~|
|CLEARSIDE BIOMEDICAL INC||S-1||J.P. Morgan Securities LLC||Cowen and Company, LLC||Stifel, Nicolaus & Company, Inc. / Wedbush Securities, Inc.|
|JOHNSON CONTROLS INTERNATIONAL PLC||S-4||Merrill Lynch, Pierce, Fenner & Smith Inc.||Citigroup Global Markets Inc.||Barclays Capital Inc. / J.P. Morgan Securities LLC / MUFG Securities Americas Inc. / Wells Fargo Securities, LLC|
|RECRO PHARMA INC||S-1||Piper Jaffray & Co.||~||~|
|MOLECULIN BIOTECH INC||S-1||Roth Capital Partners, LLC||National Securities Corp.||~|
Post IPO, thousands of organizations count on us to assure regulatory compliance and shareholder communications.
Click here to review the week’s IPOs and active securities law firms. Click here and opt-in to receive this weekly summary via email.
Have a great week.